NEA 15 GP, LLC's Net Worth

$0

Estimate Recalculated Nov 11, 2024 01:51PM EST

Who is NEA 15 GP, LLC

NEA 15 GP, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., AVEO PHARMACEUTICALS INC, IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, Achaogen Inc, Bright Health Group Inc., and ARDELYX, INC..

SEC CIK

NEA 15 GP, LLC's CIK is 0001640033

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Berkshire Grey, Inc.

Investor
Updated Jul 24, 2023
Form 4
-100.00%
-38.18M
Jul 24, 2023
Disposition
Jul 20
Form 3
Jul 30, 2021
38.18M
Showing 2 results

Nightstar Therapeutics plc

Investor
Updated Jun 07, 2019
Form 4
-100.00%
-6.66M
$25.50
-$169.89M
Jun 07, 2019
Disposition
Jun 07
Form 3
Jan 02, 2019
6.66M
Showing 2 results

Reneo Pharmaceuticals, Inc.

Investor
Updated Apr 15, 2021
Form 4
-74.04%
-13.65M
$15.00
Apr 15, 2021
4.79M
Buy-Options
Apr 13
Form 3
Apr 08, 2021
Showing 2 results

Arcellx, Inc.

Investor
Updated Dec 22, 2022
Form 4
-29.65%
-2.00M
Dec 22, 2022
4.75M
Disposition
Dec 20
Form 4
4.86%
312.50K
$16.00
$5.00M
Jun 23, 2022
6.75M
Purchase
Jun 21
Form 4
32.65%
1.58M
$15.00
$23.75M
Feb 09, 2022
6.43M
Purchase
Feb 08
Form 3
Feb 03, 2022
Showing 4 results

IonQ, Inc.

Investor
Updated Nov 18, 2022
Form 4
-44.44%
-11.69M
Nov 18, 2022
14.61M
Disposition
Nov 16
Form 4
-10.00%
-2.92M
$5.84
-$17.07M
May 31, 2022
26.31M
Sale
May 26 - May 31
Form 3
Oct 04, 2021
29.23M
Showing 3 results

Senti Biosciences, Inc.\

Investor
Updated Jun 15, 2022
Form 3
Jun 15, 2022
4.43M
Showing 1 results

Cascadian Therapeutics, Inc.

Investor
Updated Mar 13, 2018
Form 4
-100.00%
-10.88M
Mar 13, 2018
Disposition
Mar 09
Form 4
$3.30
$6.00M
Feb 22, 2018
10.88M
Options
Feb 20
Form 3
Feb 01, 2017
9.06M
Showing 3 results

Robinhood Markets, Inc.

Investor
Updated May 04, 2022
Form 4
-50.00%
-23.82M
May 04, 2022
23.82M
Disposition
May 02
Form 4
-33.37%
-23.87M
Feb 01, 2022
47.65M
Disposition
Jan 28
Form 4
-1.96%
-1.43M
Nov 12, 2021
71.51M
Disposition
Nov 10
Form 4
-1.92%
-1.43M
Oct 29, 2021
72.94M
Disposition
Oct 27
Form 4
$26.60
Aug 03, 2021
74.37M
Options
Aug 02
Form 3
Jul 29, 2021
2.51M
Showing 6 results

Nkarta, Inc.

Investor
Updated Jul 16, 2020
Form 4
29.82%
666.67K
$18.00
Jul 16, 2020
2.90M
Purchase
Jul 14
Form 3
Jul 09, 2020
Showing 2 results

AVEO PHARMACEUTICALS, INC.

Investor
Updated Oct 21, 2022
Form 4
-100.00%
-3.95M
Oct 21, 2022
Disposition
Oct 19
Form 4
56.59%
1.43M
$5.25
$7.50M
Jun 22, 2020
3.95M
Purchase
Jun 19
Form 4
41.61%
8.70M
$0.58
$5.00M
Apr 08, 2019
29.59M
Purchase
Apr 08
Form 4
2.45%
500.00K
$1.55
$774.44K
Dec 21, 2018
20.90M
Purchase
Dec 20 - Dec 21
Form 4
0.30%
61.20K
$1.98
$121.08K
Dec 12, 2018
20.40M
Purchase
Dec 11
Form 4
0.85%
170.40K
$1.99
$338.35K
Dec 10, 2018
20.33M
Purchase
Dec 06 - Dec 10
Form 4
0.48%
96.40K
$1.98
$190.89K
Nov 30, 2018
20.16M
Purchase
Nov 28 - Nov 30
Form 4
0.85%
170.00K
$1.98
$336.11K
Nov 21, 2018
20.07M
Purchase
Nov 20
Form 4
6.42%
1.20M
$1.86
$2.24M
Nov 19, 2018
19.90M
Purchase
Nov 15 - Nov 19
Form 4
3.68%
663.72K
$2.26
$1.50M
Aug 22, 2018
18.70M
Purchase
Aug 21
Form 4
1.41%
250.60K
$1.96
$491.74K
Jul 20, 2018
18.03M
Purchase
Jul 18 - Jul 19
Form 4
1.09%
192.43K
$2.10
$404.08K
Jun 28, 2018
17.78M
Purchase
Jun 27 - Jun 28
Form 4
0.00%
275.00
$2.15
$591.25
May 30, 2018
17.59M
Purchase
May 30
Form 4
1.36%
236.48K
$2.13
$503.42K
May 21, 2018
17.59M
Purchase
May 17 - May 21
Form 4
0.41%
70.87K
$2.13
$151.25K
May 10, 2018
17.35M
Purchase
May 08
Form 4
5.63%
920.98K
$2.30
$2.12M
Apr 10, 2018
17.28M
Purchase
Apr 06 - Apr 10
Form 4
57.90%
6.00M
$0.50
$3.00M
Mar 29, 2017
16.36M
Purchase
Mar 28
Form 3
May 17, 2016
10.36M
Showing 18 results

Desktop Metal, Inc.

Investor
Updated Jun 10, 2021
Form 4
-31.84%
-9.00M
Jun 10, 2021
19.26M
Disposition
Jun 08
Form 3
Dec 11, 2020
28.26M
Showing 2 results

Inozyme Pharma, Inc.

Investor
Updated Jul 28, 2020
Form 4
11.43%
250.00K
$16.00
Jul 28, 2020
2.44M
Purchase
Jul 28
Form 3
Jul 23, 2020
Showing 2 results

Millendo Therapeutics, Inc.

Investor
Updated Dec 11, 2018
Form 3
Dec 11, 2018
1.77M
Showing 1 results

Eargo, Inc.

Investor
Updated May 26, 2021
Form 4
-30.67%
-2.00M
May 26, 2021
4.52M
Disposition
May 24
Form 4
42.40%
1.94M
$18.00
Oct 22, 2020
6.52M
Purchase
Oct 20
Form 3
Oct 15, 2020
Showing 3 results

Annexon, Inc.

Investor
Updated Jul 23, 2020
Form 3
Jul 23, 2020
Showing 1 results

ARCA biopharma, Inc.

Investor
Updated Feb 27, 2018
Form 4
-100.00%
-1.46M
$0.50
-$731.27K
Feb 27, 2018
Sale
Feb 26
Form 3
Jun 17, 2015
10.22M
Showing 2 results

Achaogen Inc

Investor
Updated Jun 07, 2016
Form 3
Jun 07, 2016
4.72M
Showing 1 results

Bright Health Group Inc.

Investor
Updated Apr 10, 2024
Form 4
123.73K
Apr 10, 2024
123.73K
Purchase
Apr 08
Form 4
37.88%
30.37M
Jun 30, 2021
110.54M
Options
Jun 28
Form 3
Jun 24, 2021
46.86M
Showing 3 results

ARDELYX, INC.

Investor
Updated Dec 09, 2019
Form 4
12.98%
400.00K
$6.25
$2.50M
Dec 09, 2019
6.56M
Grant
Dec 09
Form 4
15.63%
833.33K
$4.00
$3.33M
May 30, 2018
6.16M
Grant
May 25
Form 4
40.15%
1.53M
$8.73
$13.33M
Jul 20, 2016
5.33M
Purchase
Jul 18
Form 4
35.67%
1.00M
$10.00
$10.00M
Jan 14, 2016
3.80M
Purchase
Jan 13
Form 3
Jan 14, 2016
2.80M
Showing 5 results